Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein - PubMed (original) (raw)

Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein

J M Yingling et al. Mol Cell Biol. 1997 Dec.

Abstract

Members of the Smad family of proteins are thought to play important roles in transforming growth factor beta (TGF-beta)-mediated signal transduction. In response to TGF-beta, specific Smads become inducibly phosphorylated, form heteromers with Smad4, and undergo nuclear accumulation. In addition, overexpression of specific Smad combinations can mimic the transcriptional effect of TGF-beta on both the plasminogen activator inhibitor 1 (PAI-1) promoter and the reporter construct p3TP-Lux. Although these data suggest a role for Smads in regulating transcription, the precise nuclear function of these heteromeric Smad complexes remains largely unknown. Here we show that in Mv1Lu cells Smad3 and Smad4 form a TGF-beta-induced, phosphorylation-dependent, DNA binding complex that specifically recognizes a bipartite binding site within p3TP-Lux. Furthermore, we demonstrate that Smad4 itself is a DNA binding protein which recognizes the same sequence. Interestingly, mutations which eliminate the Smad DNA binding site do not interfere with either TGF-beta-dependent transcriptional activation or activation by Smad3/Smad4 cooverexpression. In contrast, mutation of adjacent AP1 sites within this context eliminates both TGF-beta-dependent transcriptional activation and activation in response to Smad3/Smad4 cooverexpression. Furthermore, concatemerized AP1 sites, in isolation, are activated by Smad3/Smad4 cooverexpression and, to a certain extent, by TGF-beta. Taken together, these data suggest that the Smad3/Smad4 complex has at least two separable nuclear functions: it forms a rapid, yet transient sequence-specific DNA binding complex, and it potentiates AP1-dependent transcriptional activation.

PubMed Disclaimer

Similar articles

• Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.
  Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM. Dennler S, et al. EMBO J. 1998 Jun 1;17(11):3091-100. doi: 10.1093/emboj/17.11.3091. EMBO J. 1998. PMID: 9606191 Free PMC article.
• The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation.
  Feng XH, Zhang Y, Wu RY, Derynck R. Feng XH, et al. Genes Dev. 1998 Jul 15;12(14):2153-63. doi: 10.1101/gad.12.14.2153. Genes Dev. 1998. PMID: 9679060 Free PMC article.
• Intracellular signaling of the TGF-beta superfamily by Smad proteins.
  Kawabata M, Imamura T, Inoue H, Hanai J, Nishihara A, Hanyu A, Takase M, Ishidou Y, Udagawa Y, Oeda E, Goto D, Yagi K, Kato M, Miyazono K. Kawabata M, et al. Ann N Y Acad Sci. 1999;886:73-82. doi: 10.1111/j.1749-6632.1999.tb09402.x. Ann N Y Acad Sci. 1999. PMID: 10667205 Review.
• Smads as transcriptional co-modulators.
  Attisano L, Wrana JL. Attisano L, et al. Curr Opin Cell Biol. 2000 Apr;12(2):235-43. doi: 10.1016/s0955-0674(99)00081-2. Curr Opin Cell Biol. 2000. PMID: 10712925 Review.

Cited by

• Role of Natural Binding Proteins in Therapy and Diagnostics.
  Eigenfeld M, Lupp KFM, Schwaminger SP. Eigenfeld M, et al. Life (Basel). 2024 May 15;14(5):630. doi: 10.3390/life14050630. Life (Basel). 2024. PMID: 38792650 Free PMC article.
• Discovery of a new class of integrin antibodies for fibrosis.
  Zhang J, Wang T, Saigal A, Johnson J, Morrisson J, Tabrizifard S, Hollingsworth SA, Eddins MJ, Mao W, O'Neill K, Garcia-Calvo M, Carballo-Jane E, Liu D, Ham T, Zhou Q, Dong W, Meng HW, Hicks J, Cai TQ, Akiyama T, Pinto S, Cheng AC, Greshock T, Marquis JC, Ren Z, Talukdar S, Shaheen HH, Handa M. Zhang J, et al. Sci Rep. 2021 Jan 22;11(1):2118. doi: 10.1038/s41598-021-81253-0. Sci Rep. 2021. PMID: 33483531 Free PMC article.
• TGFB1/INHBA Homodimer/Nodal-SMAD2/3 Signaling Network: A Pivotal Molecular Target in PDAC Treatment.
  Abdel Mouti M, Pauklin S. Abdel Mouti M, et al. Mol Ther. 2021 Mar 3;29(3):920-936. doi: 10.1016/j.ymthe.2021.01.002. Epub 2021 Jan 9. Mol Ther. 2021. PMID: 33429081 Free PMC article. Review.
• TGF-β1 induces VEGF expression in human granulosa-lutein cells: a potential mechanism for the pathogenesis of ovarian hyperstimulation syndrome.
  Fang L, Li Y, Wang S, Li Y, Chang HM, Yi Y, Yan Y, Thakur A, Leung PCK, Cheng JC, Sun YP. Fang L, et al. Exp Mol Med. 2020 Mar;52(3):450-460. doi: 10.1038/s12276-020-0396-y. Epub 2020 Mar 10. Exp Mol Med. 2020. PMID: 32152452 Free PMC article.
• Mediator Condensates Localize Signaling Factors to Key Cell Identity Genes.
  Zamudio AV, Dall'Agnese A, Henninger JE, Manteiga JC, Afeyan LK, Hannett NM, Coffey EL, Li CH, Oksuz O, Sabari BR, Boija A, Klein IA, Hawken SW, Spille JH, Decker TM, Cisse II, Abraham BJ, Lee TI, Taatjes DJ, Schuijers J, Young RA. Zamudio AV, et al. Mol Cell. 2019 Dec 5;76(5):753-766.e6. doi: 10.1016/j.molcel.2019.08.016. Epub 2019 Sep 25. Mol Cell. 2019. PMID: 31563432 Free PMC article.

References

1. 1. Nature. 1997 Jul 3;388(6637):82-7 - PubMed
2. 1. J Biol Chem. 1997 May 23;272(21):13690-6 - PubMed
3. 1. Nature. 1997 Jul 17;388(6639):304-8 - PubMed
4. 1. Nature. 1997 Sep 4;389(6646):85-9 - PubMed
5. 1. Cell. 1990 Feb 9;60(3):375-86 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Taylor & Francis

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal